Concepedia

M. Depré

MD

Statistics

Publications

9

Citations

271

H-Index

9

Active since

1992

Affiliations

KU Leuven(Current)

MSD (Belgium)

Merck & Co., Inc., Rahway, NJ, USA (United States)

United States Military Academy

Universitair Ziekenhuis Leuven

M. Depré is an author at KU Leuven specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1992–2009

9

Publications

9

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin

M. Depré, Anne Van Hecken, Merel Oeyen et al. · European Journal of Clinical Pharmacology · 2005 · 65 citations

, , +7

Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist

Eseng Lai, LA Wenning, TM Crumley et al. · Clinical Pharmacology & Therapeutics · 2007 · 47 citations

Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine?

Bart Van der Schueren, Martin W. Lunnon, Bart Laurijssens et al. · The Journal of Clinical Pharmacology · 2009 · 38 citations

, , +18

The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers

A. Van Hecken, M. Depré, Inge De Lepeleire et al. · European Journal of Clinical Pharmacology · 2007 · 33 citations

, , +5

Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase—activating protein inhibitor

M. Depré, Beth S. Friedman, Anne Van Hecken et al. · Clinical Pharmacology & Therapeutics · 1994 · 26 citations

Rows per page

1–5 of 9